Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 190.4 USD 4.45% Market Closed
Market Cap: 5.5B USD
Have any thoughts about
Krystal Biotech Inc?
Write Note

Income Statement

Earnings Waterfall
Krystal Biotech Inc

Revenue
241.5m USD
Cost of Revenue
-18m USD
Gross Profit
223.5m USD
Operating Expenses
-158.6m USD
Operating Income
65m USD
Other Expenses
-12.6m USD
Net Income
52.4m USD

Income Statement
Krystal Biotech Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
9
N/A
51
+492%
96
+89%
166
+73%
242
+45%
Gross Profit
Cost of Revenue
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(3)
(6)
(12)
(18)
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
8
N/A
48
+471%
90
+90%
155
+71%
224
+44%
Operating Income
Operating Expenses
(1)
(2)
(2)
(4)
(5)
(7)
(8)
(9)
(12)
(14)
(18)
(20)
(22)
(23)
(24)
(29)
(33)
(41)
(51)
(57)
(68)
(79)
(92)
(107)
(120)
(131)
(141)
(143)
(145)
(146)
(151)
(159)
Selling, General & Administrative
(0)
(1)
(1)
(1)
(2)
(2)
(3)
(3)
(4)
(5)
(6)
(6)
(6)
(7)
(9)
(12)
(15)
(21)
(27)
(32)
(40)
(48)
(56)
(67)
(78)
(86)
(94)
(98)
(98)
(100)
(102)
(107)
Research & Development
(1)
(1)
(1)
(3)
(3)
(4)
(6)
(6)
(8)
(9)
(12)
(14)
(16)
(16)
(15)
(17)
(18)
(21)
(24)
(25)
(28)
(31)
(35)
(41)
(42)
(45)
(47)
(46)
(46)
(45)
(49)
(51)
Operating Income
(1)
N/A
(2)
-41%
(2)
-32%
(4)
-83%
(5)
-22%
(7)
-38%
(8)
-26%
(9)
-11%
(12)
-30%
(14)
-20%
(18)
-24%
(20)
-13%
(22)
-10%
(23)
-6%
(24)
-5%
(29)
-18%
(33)
-15%
(41)
-25%
(51)
-23%
(57)
-12%
(68)
-20%
(79)
-16%
(92)
-16%
(107)
-17%
(120)
-12%
(131)
-9%
(141)
-7%
(135)
+4%
(97)
+28%
(55)
+43%
4
N/A
65
+1 512%
Pre-Tax Income
Interest Income Expense
(0)
(0)
(0)
(3)
(3)
(3)
(3)
1
1
1
2
3
3
3
3
2
1
(1)
(1)
(1)
(1)
0
1
3
5
9
13
18
23
27
29
30
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(25)
(25)
(25)
(25)
(13)
(13)
88
88
88
75
(38)
Pre-Tax Income
(1)
N/A
(2)
-43%
(2)
-34%
(7)
-225%
(8)
-11%
(10)
-21%
(11)
-16%
(9)
+23%
(11)
-27%
(13)
-18%
(16)
-24%
(17)
-9%
(19)
-9%
(20)
-6%
(22)
-7%
(27)
-24%
(32)
-19%
(43)
-33%
(52)
-22%
(58)
-11%
(70)
-20%
(104)
-49%
(115)
-11%
(130)
-12%
(140)
-8%
(135)
+3%
(140)
-4%
(30)
+79%
13
N/A
59
+358%
108
+83%
57
-47%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
0
(2)
(5)
Income from Continuing Operations
(1)
(2)
(2)
(7)
(8)
(10)
(11)
(9)
(11)
(13)
(16)
(17)
(19)
(20)
(22)
(27)
(32)
(43)
(52)
(58)
(70)
(104)
(115)
(130)
(140)
(135)
(140)
(30)
11
57
106
52
Net Income (Common)
(1)
N/A
(2)
-43%
(2)
-34%
(7)
-225%
(8)
-11%
(10)
-21%
(11)
-16%
(9)
+23%
(11)
-27%
(13)
-18%
(16)
-24%
(17)
-9%
(19)
-9%
(20)
-6%
(22)
-7%
(27)
-24%
(32)
-19%
(43)
-33%
(52)
-22%
(58)
-11%
(70)
-20%
(104)
-49%
(115)
-11%
(130)
-12%
(140)
-8%
(135)
+3%
(140)
-4%
(30)
+79%
11
N/A
57
+423%
106
+85%
52
-51%
EPS (Diluted)
-0.13
N/A
-0.19
-46%
-0.26
-37%
-0.69
-165%
-0.77
-12%
-0.92
-19%
-1.08
-17%
-0.82
+24%
-0.97
-18%
-0.89
+8%
-1.09
-22%
-1
+8%
-1.2
-20%
-1.17
+3%
-1.18
-1%
-1.37
-16%
-1.71
-25%
-2
-17%
-2.34
-17%
-2.61
-12%
-3.13
-20%
-4.13
-32%
-4.51
-9%
-5.06
-12%
-5.49
-8%
-5.28
+4%
-5.26
+0%
-1.03
+80%
0.39
N/A
1.95
+400%
3.57
+83%
1.77
-50%

See Also

Discover More